Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 37, 2023 - Issue 10
316
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Synthesis and anticancer activity of novel Eugenol derivatives against breast cancer cells

ORCID Icon
Pages 1632-1640 | Received 27 Apr 2022, Accepted 10 Jul 2022, Published online: 25 Jul 2022

References

  • Abdel-Razek AS, El-Naggar ME, Allam A, Morsy OM, Othman SI. 2020. Microbial natural products in drug discovery. Processes. 8(4):470.
  • Alam MM. 2022. 1,2,3-triazoles as anticancer agents-A Review. Arch Der Pharm. 355(1):2100158.
  • Alam MM, Malebari AM, Nazreen S, Neamatallah T, Almalki ASA, Elhenawy AA, Obaid RJ, Alsherif MA. 2021. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells Bioorg Med Chem. 38:1–13.
  • Almalki ASA, Nazreen S, Malebari AM, Ali NM, Elhenawy AA, Alghamdi AA, Ahmad A, Alfaifi SYM, Alsharif MA, Alam MM. 2021. Synthesis and biological evaluation of 1,2,3-triazole tethered thymol-1,3,4-oxadiazole derivatives as anticancer and antimicrobial agents. Pharmaceuticals. 14(9):866–885.
  • Alvarenga DJ, Matias LMF, Finotti C, de Souza TB, Lavorato SN, Pereira MGAG, Dias DF, Carvalho DT. 2020. Synthesis of eugenol-derived glucosides and evaluation of their ability in inhibiting the angiotensin converting enzyme. Nat Prod Res.36(9):2246-2253
  • Alzahrani HA, Alam MM, Elhenawy AA, Malebari AM, Nazreen S. 2022. Synthesis, antiproliferative, docking and DFT studies of benzimidazole derivatives as EGFR inhibitors. J. Mol. Struct. 1253:132265.
  • Awasthi PK, Dixit SC, Dixit N, Sinha AK. 2008. Eugenol derivatives as future potential drugs. Drugs. 1:215–220.
  • Da Silva FFM, Monte FJQ, de Lemos TLGD, Nascimento PGG, Costa AKM, De Paiva LMM. 2018. Eugenol derivatives: synthesis, characterization, and evaluation of antibacterial and antioxidant activities. Chem. Central J. 12(34):1–9
  • Daniel AN, Sartoretto SM, Schmidt G, Caparroz-Assef SM, Bersani-Amado CA, Cuman RKN. 2009. Anti-inflammatory and antinociceptive activities A of eugenol essential oil in experimental animal models. Rev Bras Farmacogn. 19(1b):212–217.
  • De Morais SM, Vila-Nova NS, Bevilaqua CML, Rondon FC, Lobo CH, Moura AAAN, Sales AD, Rodrigues APR, Figuireido JR, Campello CC, et al. 2014. Thymol and eugenol derivatives as potential antileishmanial agents. Bioorg Med Chem. 22(21):6250–6255.
  • Eyambe G, Canales L, Banik B. 2011. Antimicrobial activity of eugenol derivatives. Heterocyc Lett. 1(2):154–157.
  • Fernandes MJG, Pereira RB, Pereira DM, Fortes AG, Castanheira EMS, Goncalves MST. 2020. New Eugenol Derivatives with Enhanced Insecticidal Activity. IJMS. 21(23):9257.
  • Fonseca DV, Salgado PRR, Neto A, Golzio HDC, Filho AMFO, Melo MRDC, Leite CGF, Piuvezam FC, Pordeus MR, Filho LCDM, et al. 2016. Ortho-eugenol exhibits anti-nociceptive and anti-inflammatory activities. Int Immunopharmacol. 38:402–408.
  • Gordaliza M. 2007. Natural products as leads to anticancer drugs. Clin Transl Oncol. 9(12):767–776.
  • Hidalgo ME, De la Rosa C, Carrasco H, Cardona W, Gallardo C, Espinoza L. 2009. Antioxidant capacity of eugenol derivatives. Quím Nova. 32(6):1467–1470.
  • Koehn FE, Carter GT. 2005. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 4(3):206–220.
  • Majeed R, Sangwan PL, Chinthakindi PK, Khan I, Dangroo NA, Thota N, Hamid A, Sharma PR, Saxena AK, Koul S. 2013. Synthesis of 3-O-propargylated betulinic acid and its 1,2,3-triazoles as potential apoptotic agents. Eur J Med Chem. 63:782–792.
  • Maurya AK, Agarwal K, Gupta AC, Saxena A, Nooreen Z, Tandon S, Ahmad A, Bawankule DU. 2018. Synthesis of eugenol derivatives and its anti-inflammatory activity against skin inflammation. Nat Prod Res.34(2):251-260.
  • Nam H, Kim MM. 2013. Eugenol with antioxidant activity inhibits MMP-9 related to metastasis in human fibrosarcoma cells. Food Chem Toxicol. 55:106–112.
  • Nazreen S. 2021. Design, synthesis, and molecular docking studies of thiazolidinediones as PPAR-γ agonists and thymidylate synthase inhibitors. Arch Pharm (Weinheim). 354(9):210002.
  • Sun W-J, Lv W-J, Li L-N, Yin G, Hang X, Xue Y, Chen J, Shi Z. 2016. Eugenol confers resistance to Tomato yellow leaf curl virus (TYLCV) by regulating the expression of SlPer1 in tomato plants. N Biotechnol. 33(3):345–354.
  • Teixeira RR, Gazolla PAR, da Silva AM, Borsodi MPG, Bergmann BR, Ferreira RS, Vaz BG, Vasconcelos GA, Lima WP. 2018. Synthesis and leishmanicidal activity of eugenol derivatives bearing 1,2,3-triazole functionalities. Eur J Med Chem. 146:274–286.
  • Zheng GQ, Kenney PM, Lam LK. 1992. Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents. J Nat Prod. 55(7):999–1003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.